marijuana stocks news

GW Pharmaceuticals Continues To Rally: A Technical Look

Joel Elconin is the co-host of Benzinga’s #PreMarket Prep, a daily trading idea radio show.

GW Pharmaceuticals Plc (NASDAQ:GWPH) shares were trading higher by $2.20 (2.5 percent) at $97.86 in Monday’s session. The darling of the marijuana sector is following through on Friday’s impressive nearly $11.00 rally ($84.58 to $95.66). It should be noted Friday’s rally took place on extremely high volume for the issue of nearly two million shares vs. its 20-day average of 325,000.

Investors may be anticipating positive results as the company is set to release additional Epidiolex data at the American Academy of Neurology that should inform developments in other orphan epilepsy. Over the past year, the issue has fluctuated primarily based on news concerning the drug and not so much on developments related to marijuana.

See Also: 15 Marijuana Stocks To Watch In 2015

After a bit off profit-taking off the open, it quickly found support just $0.16 from its opening price ($94.23 vs. $94.39) before ripping north once again. At time of writing, it easily surpassed Friday’s high ($95.92), reaching $98.43 before taking a breather.

The all-time high for the issue was made in July 2014, at the pinnacle of the “pot stock” mania at $111.46, before cascading to $58.16 in October.

See more from Benzinga


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

AgraFlora Organics International Inc. (AGRA) (AGFAF) to Import Toronto Wolfpack CBD Performance Products to Japan and Hong Kong

AgraFlora Organics to Import Toronto Wolfpack CBD Performance Products to Japan and…

Trulieve Cannabis Corp. (TCNNF) to Begin Adult-Use Cannabis Sales at Relocated Bristol, CT Dispensary

Trulieve to Begin Adult-Use Cannabis Sales at Relocated Bristol, CT Dispensary Trulieve…

Tilray, Inc. (TLRY) to Announce Second Quarter Fiscal 2022 Financial Results on January 10, 2022

Tilray to Announce Second Quarter Fiscal 2022 Financial Results on January 10,…

Cara Therapeutics, Inc. (CARA) Announces No Modifications in Trial Size After Completion of Interim Statistical Assessment

Cara Therapeutics Announces No Modifications in Trial Size After Completion of Interim…